Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IkappaB Kinase Epsilon: a Distinct Upstream Kinase Mediates Ser-172 Phosphorylation and Activation

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2009 Mar 25

PMID 19307177

Citations 203

Authors

Kristopher Clark

Lorna Plater

Mark Peggie

Philip Cohen

Affiliations

Soon will be listed here.

Abstract

TANK-binding kinase 1 (TBK1) and IkappaB kinase epsilon (IKKepsilon) regulate the production of Type 1 interferons during bacterial and viral infection, but the lack of useful pharmacological inhibitors has hampered progress in identifying additional physiological roles of these protein kinases and how they are regulated. Here we demonstrate that BX795, a potent and relatively specific inhibitor of TBK1 and IKKepsilon, blocked the phosphorylation, nuclear translocation, and transcriptional activity of interferon regulatory factor 3 and, hence, the production of interferon-beta in macrophages stimulated with poly(I:C) or lipopolysaccharide (LPS). In contrast, BX795 had no effect on the canonical NFkappaB signaling pathway. Although BX795 blocked the autophosphorylation of overexpressed TBK1 and IKKepsilon at Ser-172 and, hence, the autoactivation of these protein kinases, it did not inhibit the phosphorylation of endogenous TBK1 and IKKepsilon at Ser-172 in response to LPS, poly(I:C), interleukin-1alpha (IL-1alpha), or tumor necrosis factor alpha and actually enhanced the LPS, poly(I:C), and IL-1alpha-stimulated phosphorylation of this residue. These results demonstrate that the phosphorylation of Ser-172 and the activation of TBK1 and IKKepsilon are catalyzed by a distinct protein kinase(s) in vivo and that TBK1 and IKKepsilon control a feedback loop that limits their activation by LPS, poly(I:C) and IL-1alpha (but not tumor necrosis factor alpha) to prevent the hyperactivation of these enzymes.

Citing Articles

Chronic CRYPTOCHROME deficiency enhances cell-intrinsic antiviral defences.

Major-Styles C, Munns J, Zeng A, Vanden Oever M, ONeill J, Edgar R Philos Trans R Soc Lond B Biol Sci. 2025; 380(1918):20230344.

PMID: 39842480 PMC: 11753882. DOI: 10.1098/rstb.2023.0344.

OMP38 of Carbapenem-Resistant Acinetobacter Baumannii-Mediated mtDNA Release Activates the cGAS-STING Signaling to Induce Inflammatory Response.

Yang Y, Zeng Y, Zhu J, Li J, Gu L, Wei L Adv Sci (Weinh). 2024; :e2408292.

PMID: 39629993 PMC: 11775518. DOI: 10.1002/advs.202408292.

A cytoplasmic form of EHMT1N methylates viral proteins to enable inclusion body maturation and efficient viral replication.

Biligiri K, Sharma N, Mohanty A, Sarkar D, Vemula P, Rampalli S PLoS Biol. 2024; 22(11):e3002871.

PMID: 39509467 PMC: 11575796. DOI: 10.1371/journal.pbio.3002871.

Azamollugin, a mollugin derivative, has inhibitory activity on MyD88- and TRIF-dependent pathways.

Nakajima Y, Nishino H, Takahashi K, Nugroho A, Hirasawa Y, Kaneda T J Nat Med. 2024; 79(1):36-44.

PMID: 39283364 DOI: 10.1007/s11418-024-01842-x.

Mechanism of TBK1 activation in cancer cells.

Hu L, Zhang Q Cell Insight. 2024; 3(5):100197.

PMID: 39279883 PMC: 11402294. DOI: 10.1016/j.cellin.2024.100197.

References

Schroder M, Baran M, Bowie A . Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 2008; 27(15):2147-57. PMC: 2516890. DOI: 10.1038/emboj.2008.143. View

Ananieva O, Darragh J, Johansen C, Carr J, McIlrath J, Park J . The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol. 2008; 9(9):1028-36. DOI: 10.1038/ni.1644. View

Kishore N, Huynh Q, Mathialagan S, Hall T, Rouw S, Creely D . IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. J Biol Chem. 2002; 277(16):13840-7. DOI: 10.1074/jbc.M110474200. View

Akira S, Uematsu S, Takeuchi O . Pathogen recognition and innate immunity. Cell. 2006; 124(4):783-801. DOI: 10.1016/j.cell.2006.02.015. View

Beinke S, Robinson M, Hugunin M, Ley S . Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105. Mol Cell Biol. 2004; 24(21):9658-67. PMC: 522219. DOI: 10.1128/MCB.24.21.9658-9667.2004. View

Tojima Y, Fujimoto A, Delhase M, Chen Y, Hatakeyama S, Nakayama K . NAK is an IkappaB kinase-activating kinase. Nature. 2000; 404(6779):778-82. DOI: 10.1038/35008109. View

Zhong J, Kyriakis J . Germinal center kinase is required for optimal Jun N-terminal kinase activation by Toll-like receptor agonists and is regulated by the ubiquitin proteasome system and agonist-induced, TRAF6-dependent stabilization. Mol Cell Biol. 2004; 24(20):9165-75. PMC: 517887. DOI: 10.1128/MCB.24.20.9165-9175.2004. View

Fitzgerald K, McWhirter S, Faia K, Rowe D, Latz E, Golenbock D . IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 2003; 4(5):491-6. DOI: 10.1038/ni921. View

Takeuchi O, Akira S . MDA5/RIG-I and virus recognition. Curr Opin Immunol. 2008; 20(1):17-22. DOI: 10.1016/j.coi.2008.01.002. View

10.

Feldman R, Wu J, Polokoff M, Kochanny M, Dinter H, Zhu D . Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1. J Biol Chem. 2005; 280(20):19867-74. DOI: 10.1074/jbc.M501367200. View

11.

Waterfield M, Jin W, Reiley W, Zhang M, Sun S . IkappaB kinase is an essential component of the Tpl2 signaling pathway. Mol Cell Biol. 2004; 24(13):6040-8. PMC: 480897. DOI: 10.1128/MCB.24.13.6040-6048.2004. View

12.

Soulat D, Burckstummer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A . The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 2008; 27(15):2135-46. PMC: 2453059. DOI: 10.1038/emboj.2008.126. View

13.

Shim J, Xiao C, Paschal A, Bailey S, Rao P, Hayden M . TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005; 19(22):2668-81. PMC: 1283960. DOI: 10.1101/gad.1360605. View

14.

Pomerantz J, Baltimore D . NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 1999; 18(23):6694-704. PMC: 1171732. DOI: 10.1093/emboj/18.23.6694. View

15.

Zhong B, Yang Y, Li S, Wang Y, Li Y, Diao F . The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity. 2008; 29(4):538-50. DOI: 10.1016/j.immuni.2008.09.003. View

16.

Morton S, Hesson L, Peggie M, Cohen P . Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett. 2008; 582(6):997-1002. DOI: 10.1016/j.febslet.2008.02.047. View

17.

Ryzhakov G, Randow F . SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J. 2007; 26(13):3180-90. PMC: 1914091. DOI: 10.1038/sj.emboj.7601743. View

18.

Collins B, Deak M, Murray-Tait V, Storey K, Alessi D . In vivo role of the phosphate groove of PDK1 defined by knockin mutation. J Cell Sci. 2005; 118(Pt 21):5023-34. DOI: 10.1242/jcs.02617. View

19.

Pullen N, Dennis P, Andjelkovic M, Dufner A, Kozma S, Hemmings B . Phosphorylation and activation of p70s6k by PDK1. Science. 1998; 279(5351):707-10. DOI: 10.1126/science.279.5351.707. View

20.

Buss H, Dorrie A, Schmitz M, Hoffmann E, Resch K, Kracht M . Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase.... J Biol Chem. 2004; 279(53):55633-43. DOI: 10.1074/jbc.M409825200. View